EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

Autor: Gori, S. *, Sidoni, A., Colozza, M., Ferri, I., Mameli, M.G., Fenocchio, D., Stocchi, L., Foglietta, J., Ludovini, V., Minenza, E., De Angelis, V., Crinò, L.
Zdroj: In Annals of Oncology April 2009 20(4):648-654
Databáze: ScienceDirect